Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-11001554Phase 4Completed
Phase 4 trial of rukangshu in breast hyperplasia (2 arms), sponsored by Beijing Fengtai District Committee of Science and Technology. Primary endpoints: Breast mass size, Effect of disease and 3 more. Started Apr 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-11001554.